Tim Riley has been involved with the commercialization of mass spectrometry instrumentation since 1984 when he joined VG Instruments, which was acquired by Fisons Instruments in 1990, and then spun off as Micromass in 1996. Then, in 1997, Waters purchased Micromass and Riley served as president of the US sales and services division. Currently, Riley is vice president of proteomics business development for Waters. BioCommerce Week spoke to Riley recently to get a view of the company’s business development strategy for proteomics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.